Table 2.

Outcomes and Subsequent Procedures.^*

Variable	CABG Alone (N = 499)	CABG with Surgical Ventricular Reconstruction (N = 501)	Hazard Ratio (95% CI)	P Value
	number (percent)
Outcome
Death from any cause or hospitalization for cardiac causes	292 (59)	289 (58)	0.99 (0.84–1.17)	0.90
Death from any cause	141 (28)	138 (28)	1.00 (0.79–1.26)	0.98
Death from any cause within 30 days after randomization (intention-to-treat analysis)	22 (4)	30 (6)		0.26
Death from any cause within 30 days after surgery†
Intention-to-treat analysis	25 (5)	26 (5)		0.88
As-treated analysis	23 (5)	28 (6)		0.40
Hospitalization
For any cause	272 (55)	268 (53)	0.98 (0.83–1.16)	0.82
For cardiac causes	211 (42)	204 (41)	0.97 (0.80–1.18)	0.73
Acute myocardial infarction	22 (4)	20 (4)	1.01 (0.54–1.87)	0.96
Stroke	31 (6)	23 (5)	0.77 (0.45–1.32)	0.35
Subsequent procedure‡
CABG	0	1 (<1)
Placement of left ventricular assist device	2 (<1)	2 (<1)
Heart transplantation	2 (<1)	7 (1)
Percutaneous coronary intervention	32 (6)	17 (3)
Placement of pacemaker
For resynchronization	31 (6)	30 (6)
For heart rate	44 (9)	47 (9)
Placement of implantable cardioverter–defibrillator	100 (20)	86 (17)

^*Hazard ratios are for coronary-artery bypass grafting (CABG) with surgical ventricular reconstruction as compared with CABG alone.

^†For the analysis of death within 30 days after surgery, in the group that was assigned to undergo CABG alone, 490 patients were evaluated in the intention-to-treat analysis and 498 patients in the as-treated analysis; in the group that was assigned to undergo CABG with surgical ventricular reconstruction, 489 patients were evaluated in the intention-to-treat analysis and 481 patients in the as-treated analysis.

^‡ Hazard ratios and P values are not provided for subsequent procedures because of the low incidence of these events.